Tempest Therapeutics, Inc. Deferred Offering Costs
Tempest Therapeutics, Inc. (TPST) had Deferred Offering Costs of $200.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2019-11-13
- 2019-09-30: Deferred Offering Costs $200.00K.
- 2019-06-30: Deferred Offering Costs $200.00K.
- 2014-12-31: Deferred Offering Costs $100.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-12 |
| 2014-12-31 | $100.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |